VIR - Vir stock hits new 52-week low in wake of BofA downgrade
2023-09-08 11:40:55 ET
More on Vir Biotechnology
- Seeking Alpha’s Quant Rating on Vir Biotechnology
- Historical earnings data for Vir Biotechnology
- Financial information for Vir Biotechnology
- Vir Biotechnology: Strong Balance Sheet But Commercial Prospects Await Further Clarity
- Vir Biotechnology, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Vir Biotechnology, Inc. ( VIR ) Q2 2023 Earnings Call Transcript
- Vir Biotechnology Sneezes On Flu Data, But May Be Worth Holding
- Vir Biotech plunges as mid-stage study for flu candidate fails
For further details see:
Vir stock hits new 52-week low in wake of BofA downgrade